Srivatsan Raghavan

Dana-Farber Cancer Inst

$1,164,735

Attributed

$1,164,735

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $301.5K · FY2022–25

$500K$375K$250K$125K$0

'22

'23

'24

'25

Funding mix

By agency

NIH$1,164,735 · 1

By mechanism

K08$1,164,735 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Others in their field

Other Rising Stars on “Drug Sensitivity”

Maximilian Haeussler · University Of California Santa Cruz$12,592,563
Javier Caravaca · University Of California, San Francisco$3,728,080
C.k. Osborne · Leidos Biomedical Research, Inc.$3,516,733
Farshad Tehrani · Actiox Llc$3,301,618
Daniel Paech · Brigham And Women'S Hospital$3,155,815
Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation$3,065,252

Research focus

Drug SensitivityAdvisory CommitteesAdoptedAwardBasal CellBasal Cell CancerAreaBiological MarkersBiomedical EngineeringBiopsyCancer BiologyCareer DevelopmentCellsChemoresistanceChemotherapeutic AgentChemotherapyCholangiocarcinomaChronicClustered Regularly Interspaced Short Palindromic RepeatsCommittee MembersCrispr ScreenDana-Farber Cancer InstituteDrug ResistanceEffective Therapy

Grant awards (4)

Regulation and targeting of tumor cell states and plasticity in pancreatic cancer$301,496

K08 · FY2025 · CA · contact PI

Regulation and targeting of tumor cell states and plasticity in pancreatic cancer$301,496

K08 · FY2024 · CA · contact PI

Regulation and targeting of tumor cell states and plasticity in pancreatic cancer$301,496

K08 · FY2023 · CA · contact PI

Regulation and targeting of tumor cell states and plasticity in pancreatic cancer$260,247

K08 · FY2022 · CA · contact PI